BioNTech Leadership Exodus Triggers 18% Stock Plunge Amid Weak 2026 Guidance

Therma Bright Grants 2.85M Stock Options Amid Biotech Diagnostic Push

Immutep Shares Plunge 93% as Phase III Cancer Trial Halted on Futility Analysis

Merck's Keytruda Wins FDA Approval for New Gastric Cancer Indication, Boosting Oncology Pipeline

Pfizer's High-Stakes Pivot to Oncology and Obesity: A 2026 Turning Point for Biotech Investors

Telix Pharmaceuticals' ProstACT Global Phase 3 Milestone Ignites Biotech Momentum in Prostate Cancer Treatment

Dianthus Therapeutics Gears Up for Pivotal Phase 3 Interim Data Reveal in CIDP, Stock Poised for Momentum

Iovance Biotherapeutics Emerges as Top Biotech Watch Amid Surging Trading Volume and Melanoma Therapy Momentum

Novo Nordisk Receives FDA Breakthrough Designation for GLP-1 Combination Therapy in Obesity Management

Merck's Keytruda Wins FDA Approval for New Cancer Indication, Boosting Biotech Momentum

Novo Nordisk Faces Patent Challenge as GLP-1 Competitor Gains FDA Momentum

Vertex Pharmaceuticals Q4 Earnings Beat Signals Biotech Powerhouse Expansion Beyond CF

Syndax Pharmaceuticals Achieves Third FDA Approval in 12 Months, Pivots to Multi-Product Revenue Model

Generate Biomedicines' $400M IPO Signals Renewed Investor Appetite for AI-Driven Drug Discovery

Generate Biomedicines Raises $400M in Blockbuster IPO, Signaling Biotech Revival Amid AI Drug Discovery Boom

Torrent Pharmaceuticals Hits All-Time High: 606% Decade-Long Surge Signals Biotech Resilience Amid Sector Volatility

Raymond James Upgrades Vir Biotechnology to Strong Buy on Promising Drug Data, Signaling Biotech Momentum

Moderna (MRNA) Advances mRNA Vaccine Pipeline Beyond COVID-19

Biogen (BIIB) Gains FDA Approval for New Alzheimer's Drug